Allspring Global Investments’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.35M Buy
7,322
+36
+0.5% +$6.63K ﹤0.01% 1118
2025
Q4
$1.3M Buy
7,286
+264
+4% +$43.1K ﹤0.01% 1111
2025
Q3
$1.08M Sell
7,022
-251
-3% -$33.9K ﹤0.01% 1147
2025
Q2
$946K Sell
7,273
-3,589
-33% -$447K ﹤0.01% 1177
2025
Q1
$1.43M Buy
10,862
+4,019
+59% +$575K ﹤0.01% 1164
2024
Q4
$1.03M Buy
6,843
+183
+3% +$30.9K ﹤0.01% 1289
2024
Q3
$1.29M Sell
6,660
-859
-11% -$180K ﹤0.01% 1267
2024
Q2
$1.74M Sell
7,519
-205
-3% -$44.6K ﹤0.01% 1205
2024
Q1
$1.67M Sell
7,724
-16,514
-68% -$3.87M ﹤0.01% 1242
2023
Q4
$6.27M Sell
24,238
-33,675
-58% -$8.27M 0.01% 887
2023
Q3
$14.9M Sell
57,913
-1,423
-2% -$381K 0.03% 622
2023
Q2
$16.9M Sell
59,336
-8,833
-13% -$2.63M 0.03% 646
2023
Q1
$19M Sell
68,169
-32,497
-32% -$8.99M 0.03% 617
2022
Q4
$27.9M Buy
100,666
+23,212
+30% +$6.56M 0.05% 481
2022
Q3
$20.7M Sell
77,454
-4,893
-6% -$1.04M 0.04% 556
2022
Q2
$16.8M Buy
82,347
+44,799
+119% +$9.16M 0.03% 636
2022
Q1
$7.91M Sell
37,548
-5,714
-13% -$1.24M 0.01% 969
2021
Q4
$10.4M Buy
+43,262
New +$11.1M 0.01% 908

Other funds holding BIIB

Allspring Global Investments's BIIB Position: Q1 2026 in Review

Allspring Global Investments increased its Biogen (BIIB) stake by 0.49% in Q1 2026, buying an estimated $6.63K and bringing the position to 7,322 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #1118.

Allspring Global Investments first reported a position in BIIB in Q4 2021 and has held it in 18 quarters since. The position peaked at $27.9M in Q4 2022. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Allspring Global Investments held 7,322 shares of Biogen worth $1.35M as of Q1 2026.
  • Allspring Global Investments bought 36 Biogen shares in Q1 2026, an estimated $6.63K.
  • Biogen made up ﹤0.01% of Allspring Global Investments's portfolio in Q1 2026, its #1118 holding.
  • Allspring Global Investments first reported a position in Biogen in Q4 2021 and has held it in 18 quarters since.
  • Allspring Global Investments's Biogen position peaked at $27.9M in Q4 2022.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.